» Articles » PMID: 29636432

An Evolutionarily Conserved Mechanism for Intrinsic and Transferable Polymyxin Resistance

Overview
Journal mBio
Specialty Microbiology
Date 2018 Apr 12
PMID 29636432
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Polymyxins, a family of cationic antimicrobial cyclic peptides, act as a last line of defense against severe infections by Gram-negative pathogens with carbapenem resistance. In addition to the intrinsic resistance to polymyxin E (colistin) conferred by , the plasmid-borne mobilized colistin resistance gene has been disseminated globally since the first discovery in Southern China, in late 2015. However, the molecular mechanisms for both intrinsic and transferable resistance to colistin remain largely unknown. Here, we aim to address this gap in the knowledge of these proteins. Structural and functional analyses of EptA and MCR-1 and -2 have defined a conserved 12-residue cavity that is required for the entry of the lipid substrate, phosphatidylethanolamine (PE). The and data together have allowed us to visualize the similarities in catalytic activity shared by EptA and MCR-1 and -2. The expression of either EptA or MCR-1 or -2 is shown to remodel the surface of enteric bacteria (e.g., , , , etc.), rendering them resistant to colistin. The parallels in the PE substrate-binding cavities among EptA, MCR-1, and MCR-2 provide a comprehensive understanding of both intrinsic and transferable colistin resistance. Domain swapping between EptA and MCR-1 and -2 reveals that the two domains (transmembrane [TM] region and hosphothanolmine [PEA] transferase) are not functionally exchangeable. Taken together, the results represent a common mechanism for intrinsic and transferable PEA resistance to polymyxin, a last-resort antibiotic against multidrug-resistant pathogens. EptA and MCR-1 and -2 remodel the outer membrane, rendering bacteria resistant to colistin, a final resort against carbapenem-resistant pathogens. Structural and functional analyses of EptA and MCR-1 and -2 reveal parallel PE lipid substrate-recognizing cavities, which explains intrinsic and transferable colistin resistance in gut bacteria. A similar mechanism is proposed for the catalytic activities of EptA and MCR-1 and -2. Together, they constitute a common mechanism for intrinsic and transferable polymyxin resistance.

Citing Articles

A bacterial methyltransferase that initiates biotin synthesis, an attractive anti-ESKAPE druggable pathway.

Su Z, Zhang W, Shi Y, Cui T, Xu Y, Yang R Sci Adv. 2024; 10(51):eadp3954.

PMID: 39705367 PMC: 11661456. DOI: 10.1126/sciadv.adp3954.


Membrane lipid homeostasis dually regulates conformational transition of phosphoethanolamine transferase EptA.

Ma Z, Nang S, Liu Z, Zhu J, Mu K, Xu L Nat Commun. 2024; 15(1):10166.

PMID: 39580503 PMC: 11585620. DOI: 10.1038/s41467-024-54607-1.


Sequence variation in the active site of mobile colistin resistance proteins is evolutionarily accommodated through inter-domain interactions.

Joshi A, Matange N Biochem J. 2024; 481(23):1741-1755.

PMID: 39509206 PMC: 7617329. DOI: 10.1042/BCJ20240373.


The multifaceted roles of phosphoethanolamine-modified lipopolysaccharides: from stress response and virulence to cationic antimicrobial resistance.

Schumann A, Gaballa A, Wiedmann M Microbiol Mol Biol Rev. 2024; 88(4):e0019323.

PMID: 39382292 PMC: 11653736. DOI: 10.1128/mmbr.00193-23.


PhoPQ-mediated lipopolysaccharide modification governs intrinsic resistance to tetracycline and glycylcycline antibiotics in .

Choi B, Choi U, Ryu D, Lee C mSystems. 2024; 9(10):e0096424.

PMID: 39345149 PMC: 11495068. DOI: 10.1128/msystems.00964-24.


References
1.
Liu L, Feng Y, Zhang X, McNally A, Zong Z . New Variant of in an Extensively Drug-Resistant Escherichia coli Clinical Isolate Carrying and . Antimicrob Agents Chemother. 2017; 61(12). PMC: 5700326. DOI: 10.1128/AAC.01757-17. View

2.
Stojanoski V, Sankaran B, Prasad B, Poirel L, Nordmann P, Palzkill T . Structure of the catalytic domain of the colistin resistance enzyme MCR-1. BMC Biol. 2016; 14(1):81. PMC: 5031297. DOI: 10.1186/s12915-016-0303-0. View

3.
Di Pilato V, Arena F, Tascini C, Cannatelli A, Henrici De Angelis L, Fortunato S . mcr-1.2, a New mcr Variant Carried on a Transferable Plasmid from a Colistin-Resistant KPC Carbapenemase-Producing Klebsiella pneumoniae Strain of Sequence Type 512. Antimicrob Agents Chemother. 2016; 60(9):5612-5. PMC: 4997870. DOI: 10.1128/AAC.01075-16. View

4.
Poirel L, Kieffer N, Fernandez-Garayzabal J, Vela A, Larpin Y, Nordmann P . MCR-2-mediated plasmid-borne polymyxin resistance most likely originates from Moraxella pluranimalium. J Antimicrob Chemother. 2017; 72(10):2947-2949. DOI: 10.1093/jac/dkx225. View

5.
Paterson D, Harris P . Colistin resistance: a major breach in our last line of defence. Lancet Infect Dis. 2015; 16(2):132-3. DOI: 10.1016/S1473-3099(15)00463-6. View